Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Arcadia Consumer Healthcare
Deal Size : Undisclosed
Deal Type : Acquisition
Bansk Group-Backed Arcadia Consumer Health Acquires Avrio Health
Details : Through the acquisition, Arcadia expands its portfolio of products by including Senokot®, Betadine®, Colace®, and SlowMag™ Mg. Senna glycoside, also known as sennoside or senna, is a medication used to treat constipation and empty the large intestin...
Product Name : Senokot
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
May 06, 2023
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Arcadia Consumer Healthcare
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Mouthrinse
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Recipient : University of Pennsylvania
Deal Size : Inapplicable
Deal Type : Inapplicable
Povidone-Iodine Oral Rinse Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 15, 2022
Lead Product(s) : Mouthrinse
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Recipient : University of Pennsylvania
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Purdue Pharma’s Avrio Health Launches Two Senokot® Dietary Supplement Products
Details : Senokot (Sennoside) blueberry pomegranate flavor is a new flavor of senokot laxative* gummies for gentle overnight relief for occasional constipation.
Product Name : Senokot
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 25, 2021
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable